Published in Ther Adv Urol on June 01, 2014
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol (1992) 13.63
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
Saw palmetto for benign prostatic hyperplasia. N Engl J Med (2006) 4.99
Urologic diseases in America project: benign prostatic hyperplasia. J Urol (2005) 4.09
Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. Urology (2011) 2.81
BPH: epidemiology and comorbidities. Am J Manag Care (2006) 2.01
Safety of green tea extracts : a systematic review by the US Pharmacopeia. Drug Saf (2008) 1.73
Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr (2010) 1.52
Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev (2009) 1.33
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res (2012) 1.23
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2010) 1.11
Management of lower urinary tract symptoms in men: summary of NICE guidance. BMJ (2010) 1.09
Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. BJU Int (2003) 0.99
Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation. Biochim Biophys Acta (2012) 0.93
Anti-inflammatory activity of soy and tea in prostate cancer prevention. Exp Biol Med (Maywood) (2010) 0.87
Herbs for benign prostatic hyperplasia. Ann Pharmacother (2002) 0.85
Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract (2009) 0.82
Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting. Curr Med Res Opin (2006) 0.80